STOCK TITAN

[Form 4] Myomo Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

Myomo, Inc. insider purchase: The company's CEO and director, Paul R. Gudonis, made open-market purchases totaling 50,000 shares of Myomo common stock on 08/15/2025 at a volume-weighted average price of $0.9459 per share (individual trade prices ranged from $0.9289 to $0.9687). After these purchases, Mr. Gudonis beneficially owned 1,259,013 shares directly. The filing was signed by an attorney-in-fact on behalf of the reporting person.

Acquisto da parte di un insider di Myomo, Inc.: Il CEO e membro del consiglio, Paul R. Gudonis, ha effettuato acquisti sul mercato aperto per un totale di 50.000 azioni ordinarie di Myomo il 15/08/2025, al prezzo medio ponderato per volume di $0,9459 per azione (i singoli prezzi delle operazioni sono variati da $0,9289 a $0,9687). Dopo questi acquisti, il Sig. Gudonis deteneva direttamente in via beneficiaria 1.259.013 azioni. Il modulo è stato firmato da un procuratore per conto della persona segnalante.

Compra de insider en Myomo, Inc.: El consejero delegado y miembro de la junta, Paul R. Gudonis, realizó compras en el mercado abierto por un total de 50.000 acciones ordinarias de Myomo el 15/08/2025, a un precio medio ponderado por volumen de $0,9459 por acción (los precios individuales oscilaron entre $0,9289 y $0,9687). Tras estas compras, el Sr. Gudonis poseía en beneficio directo 1.259.013 acciones. El informe fue firmado por un apoderado en nombre de la persona que informa.

Myomo, Inc. 내부자 매수: 회사의 CEO 겸 이사인 Paul R. Gudonis는 2025-08-15에 공개시장에서 Myomo 보통주 총 50,000주를 매수했으며, 거래량 가중 평균 가격은 주당 $0.9459(개별 거래 가격은 $0.9289에서 $0.9687 사이)였습니다. 이 매수 이후 Gudonis 씨는 직접 실질적으로 1,259,013주를 보유하게 되었습니다. 해당 서류는 보고인의 대리인이 서명했습니다.

Achat par un initié de Myomo, Inc. : Le PDG et administrateur, Paul R. Gudonis, a réalisé des achats sur le marché ouvert pour un total de 50 000 actions ordinaires Myomo le 15/08/2025, au prix moyen pondéré par le volume de 0,9459 $ par action (les prix des transactions individuelles variaient de 0,9289 $ à 0,9687 $). Après ces achats, M. Gudonis détenait directement à titre bénéficiaire 1 259 013 actions. Le dépôt a été signé par un mandataire au nom de la personne déclarante.

Insider-Kauf von Myomo, Inc.: Der CEO und Direktor Paul R. Gudonis tätigte am 15.08.2025 offene Marktkäufe von insgesamt 50.000 Aktien der Stammaktien von Myomo zum volumen-gewichteten Durchschnittspreis von $0,9459 je Aktie (Einzelhandelspreise lagen zwischen $0,9289 und $0,9687). Nach diesen Käufen besaß Herr Gudonis direkt wirtschaftlich 1.259.013 Aktien. Die Meldung wurde von einem Bevollmächtigten im Namen der meldenden Person unterzeichnet.

Positive
  • CEO and director purchased 50,000 open-market shares, which can be read as an insider signal of confidence
  • Direct beneficial ownership increased to 1,259,013 shares, showing a meaningful retained stake
  • Filing provides VWAP and price range, and offers additional lot-level details to the SEC on request, indicating transparency
Negative
  • None.

Insights

TL;DR: CEO purchased 50,000 open-market shares, modest insider buy increasing direct ownership to 1.26M shares—neutral-to-slightly-positive signal.

The transaction is an open-market buy executed at a VWAP of $0.9459 on 08/15/2025 for 50,000 shares, increasing the reporting person’s direct holdings to 1,259,013 shares. Open-market purchases by a CEO can be interpreted as a signal of confidence, but without context on total outstanding shares or recent trading volume the market impact is limited. The filing conforms to Section 16 reporting and discloses price range and willingness to provide lot-level details upon SEC request.

TL;DR: Insider acquisition disclosed properly; compliance and transparency are intact, materiality appears limited.

The Form 4 shows timely reporting, specifies that purchases were open-market, and provides VWAP and price range. From a governance perspective, the filing demonstrates adherence to Section 16 disclosure requirements and offers transparency by noting availability of transaction lot details. The size of the purchase relative to the total ownership stake suggests it is not a transformative event for control or governance.

Acquisto da parte di un insider di Myomo, Inc.: Il CEO e membro del consiglio, Paul R. Gudonis, ha effettuato acquisti sul mercato aperto per un totale di 50.000 azioni ordinarie di Myomo il 15/08/2025, al prezzo medio ponderato per volume di $0,9459 per azione (i singoli prezzi delle operazioni sono variati da $0,9289 a $0,9687). Dopo questi acquisti, il Sig. Gudonis deteneva direttamente in via beneficiaria 1.259.013 azioni. Il modulo è stato firmato da un procuratore per conto della persona segnalante.

Compra de insider en Myomo, Inc.: El consejero delegado y miembro de la junta, Paul R. Gudonis, realizó compras en el mercado abierto por un total de 50.000 acciones ordinarias de Myomo el 15/08/2025, a un precio medio ponderado por volumen de $0,9459 por acción (los precios individuales oscilaron entre $0,9289 y $0,9687). Tras estas compras, el Sr. Gudonis poseía en beneficio directo 1.259.013 acciones. El informe fue firmado por un apoderado en nombre de la persona que informa.

Myomo, Inc. 내부자 매수: 회사의 CEO 겸 이사인 Paul R. Gudonis는 2025-08-15에 공개시장에서 Myomo 보통주 총 50,000주를 매수했으며, 거래량 가중 평균 가격은 주당 $0.9459(개별 거래 가격은 $0.9289에서 $0.9687 사이)였습니다. 이 매수 이후 Gudonis 씨는 직접 실질적으로 1,259,013주를 보유하게 되었습니다. 해당 서류는 보고인의 대리인이 서명했습니다.

Achat par un initié de Myomo, Inc. : Le PDG et administrateur, Paul R. Gudonis, a réalisé des achats sur le marché ouvert pour un total de 50 000 actions ordinaires Myomo le 15/08/2025, au prix moyen pondéré par le volume de 0,9459 $ par action (les prix des transactions individuelles variaient de 0,9289 $ à 0,9687 $). Après ces achats, M. Gudonis détenait directement à titre bénéficiaire 1 259 013 actions. Le dépôt a été signé par un mandataire au nom de la personne déclarante.

Insider-Kauf von Myomo, Inc.: Der CEO und Direktor Paul R. Gudonis tätigte am 15.08.2025 offene Marktkäufe von insgesamt 50.000 Aktien der Stammaktien von Myomo zum volumen-gewichteten Durchschnittspreis von $0,9459 je Aktie (Einzelhandelspreise lagen zwischen $0,9289 und $0,9687). Nach diesen Käufen besaß Herr Gudonis direkt wirtschaftlich 1.259.013 Aktien. Die Meldung wurde von einem Bevollmächtigten im Namen der meldenden Person unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
GUDONIS PAUL R

(Last) (First) (Middle)
C/O MYOMO, INC.
45 BLUE SKY DR., SUITE 101

(Street)
BURLINGTON MA 01803

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
MYOMO, INC. [ MYO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/15/2025 P 50,000(1) A $0.9459(2) 1,259,013 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents open market purchases.
2. Represents volume weighted average purchase price. Shares purchased in multiple lots at purchase prices ranging from $0.9289 to $0.9687 per share. Reporting Party agrees to provide details of these transactions to the SEC upon request.
/s/ David A. Henry, Attorney-in-Fact 08/18/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Paul R. Gudonis report on the Form 4 for MYO?

The Form 4 reports that Paul R. Gudonis purchased 50,000 shares of Myomo common stock in open-market transactions on 08/15/2025.

At what price did the insider purchases occur in the MYO Form 4?

The purchases were executed at a volume-weighted average price of $0.9459 per share, with individual lot prices ranging from $0.9289 to $0.9687.

How many MYO shares does the reporting person own after the transaction?

After the reported purchases, the reporting person beneficially owned 1,259,013 shares of Myomo common stock.

Was the Form 4 filing properly executed and signed?

Yes; the filing includes a signature by an attorney-in-fact, David A. Henry, dated 08/18/2025.

Did the Form 4 disclose whether the trades were part of a trading plan?

No; the Form 4 identifies the trades as open-market purchases and does not indicate they were under a Rule 10b5-1 trading plan.
Myomo

NYSE:MYO

MYO Rankings

MYO Latest News

MYO Latest SEC Filings

MYO Stock Data

42.34M
32.46M
6.62%
66.28%
4.11%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
BOSTON